GalNac oligonucleotide conjugates, or more popularly known as the GalNAc conjugates, are the next generation drug conjugates, which use GalNac as their targeting ligand and oligonucleotide as their payload for targeted therapy. Owing to their clinical proficiency, structural stability, and tissue penetration, they have emerged as a popular next generation drug conjugate among the industry stakeholders.